Propanc Biopharma Inc (PPCB)

[Educated]

Although the stock price hasn't done well lately, it appears that PPCB is slowly executing on its strategy to prepare the company for the events that they highlighted in their (publicly available) investor brochure to begin at the end of August 2018. These are noted as: 1) CTA Preparation; 2) Investigational Medicinal Product Dossier (IMPD); 3) Investigator's Brochure.

Over the past several weeks, PPCB has sought Investment from a bevy of companies which has been reflected in their filings, and is likely in the buildup for what's to come. I'm happy to see the success that has been made to date, and have bought the dip in the stock price, along with other shareholders that have likely kept themselves informed.

At 3 cents a share, I think that the stock is a great buy, and I'll continue to buy, in hopes of reaping the benefits in the months to come.

For those of you, who haven't done the research and are sitting on the sidelines, I hope that the recent corporate investor presentation helps.

https://ir.propanc.com/